Firocoxib 189954-96-9 Anti-inflammatory NSAID
Tefo:T/T, L/C
Tšimoloho ea Sehlahisoa:China
Boema-kepe:Beijing/Shanghai/Hangzhou
Odara (MOQ):25kg
Lead time:3 matsatsi a ho sebetsa
Bokhoni ba tlhahiso:80kg / khoeli
Boemo ba polokelo:E bolokiloe sebakeng se pholileng, se omileng, mocheso oa kamore.
Lintho tsa sephutheloana:moropa
Boholo ba sephutheloana:25kg / moropa
Lintlha tsa polokeho:Eseng thepa e kotsi
Selelekela
Felrocoxib ke sethethefatsi sa bohlokoa se seng sa steroidal se khahlanong le ho ruruha, 'me phello ea eona ke haholo-holo ka ho thibela ka mokhoa o ikhethileng motsoako oa prostaglandin o kentsoeng ke cyclooxygenase-2 (COX-2) ho thibela peanut four.Asiti ea alkenoic e fetoloa prostaglandins, eo le eona e nang le antipyretic, analgesic le anti-inflammatory properties.Ha e bapisoa le lithethefatsi tse ling tse seng tsa steroidal tse thibelang ho ruruha ha liphoofolo, filocoxib e khona ho thibela COX-2 ka katleho le ka mokhoa o ikhethileng, 'me e ka kenngoa ka potlako ke' mele, e leng se nang le phello e kholo ho kokobetsa bohloko ba osteoarthritis.
Tlhaloso (ka hare ho ntlo)
| Ntho | Tlhaloso |
| Ponahalo | Phofo e tšoeu ho isa ho e tšoeu ea kristale |
| Boitsebiso | UV, IR, HPLC |
| Tahlehelo ka ho omisa | ≤0.5% |
| Masalla ha a tuka | ≤0.1% |
| Litšepe tse boima | ≤10ppm |
| Lintho tse amanang | P0Z1 ≤0.5% |
| M1Z1 ≤0.5% | |
| P0Z6 ≤0.5% | |
| P0Z7 ≤0.5% | |
| M2Z4 ≤0.5% | |
| Tšilafalo efe kapa efe ≤0.2% | |
| Kakaretso ea litšila ≤2.0% | |
| Li-solvents tse setseng | Ethanol ≤5000ppm |
| Ethyl acetate ≤5000ppm | |
| Triethylamine ≤5000ppm | |
| Acetonitrile ≤410ppm | |
| Dichloromethane ≤600ppm | |
| Tlhahlobo | 98.0% ~ 102.0% (e baloang ka motheo o omisitsoeng) |
